We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel 3D Printing Technique Installs NIV Sensors in Lab-on-a Chip Devices

By LabMedica International staff writers
Posted on 04 Nov 2016
Print article
Image: The heart-on-a-chip is made entirely using multi-material three-dimensional printing (3D) in a single automated procedure, integrating six custom printing inks at micrometer resolution (Photo courtesy of Johan Lind, Disease Biophysics Group, and Lori K. Sanders, Lewis Laboratory, Harvard University).
Image: The heart-on-a-chip is made entirely using multi-material three-dimensional printing (3D) in a single automated procedure, integrating six custom printing inks at micrometer resolution (Photo courtesy of Johan Lind, Disease Biophysics Group, and Lori K. Sanders, Lewis Laboratory, Harvard University).
A team of biomedical engineers developed an advanced three-dimensional (3D) printing technique to embed noninvasive strain sensors into living tissue as an integral component of organ-on-a-chip devices.

Microphysiological systems (MPS), also known as organs-on-chips, that recapitulate the structure and function of native tissues in vitro, have emerged as a promising alternative to the use of animals in biomedical investigations. However, current MPS typically lack integrated sensors and their fabrication requires complex and expensive multi-step lithographic processes.

Investigators at Harvard University (Cambridge, MA, USA) recently described a method for fabricating a new class of instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Specifically, they designed six functional inks, based on piezo-resistive, high-conductance, and biocompatible soft materials that enabled integration of soft strain gauge sensors within micro-architectures that guided the self-assembly of laminar cardiac tissues.

As described in the October 24, 2016, online edition of the journal Nature Materials, the chips contained multiple wells, each with separate tissues and integrated sensors, allowing investigators to study many engineered cardiac tissues at once.

The investigators validated that the embedded sensors provided non-invasive, electronic readouts of tissue contractile stresses inside cell incubator environments. They further applied these devices to study drug responses, as well as the contractile development of human stem cell-derived laminar cardiac tissues over four weeks.

"Our microfabrication approach opens new avenues for in vitro tissue engineering, toxicology, and drug screening research," said senior author Dr. Kit Parker, professor of bioengineering and applied physics at Harvard University. "Translating microphysiological devices into truly valuable platforms for studying human health and disease requires that we address both data acquisition and manufacturing of our devices. This work offers new potential solutions to both of these central challenges."

Related Links:
Harvard University

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.